Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Urothelial Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03237780
What this trial is testing

Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+21 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Testing effectiveness (Phase 2)Ended earlyNCT03472560
What this trial is testing

Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)

Who this might be right for
Non-Small Cell Lung CancerUrothelial Cancer
Pfizer 61
Early research (Phase 1)Looking for participantsNCT06582017
What this trial is testing

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Who this might be right for
Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more
Nammi Therapeutics Inc 100
Testing effectiveness (Phase 2)Looking for participantsNCT06823427
What this trial is testing

9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUrothelial Carcinoma BladderUrothelial Carcinoma Recurrent+1 more
Mabwell (Shanghai) Bioscience Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00006351
What this trial is testing

SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
European Organisation for Research and Treatment of Cancer - EORTC 34
Early research (Phase 1)UnknownNCT04603846
What this trial is testing

Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial Carcinoma

Who this might be right for
Advanced Urothelial Carcinoma
Lee's Pharmaceutical Limited 20
Testing effectiveness (Phase 2)Study completedNCT05219435
What this trial is testing

Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Urothelial Cancer
Spanish Oncology Genito-Urinary Group 25
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Testing effectiveness (Phase 2)Looking for participantsNCT05239624
What this trial is testing

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

Who this might be right for
Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT01265940
What this trial is testing

Pazopanib and Vinflunine in Urothelial Cancer of the Bladder

Who this might be right for
Advanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy.
Prof. Dr. Thomas Otto 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT00365157
What this trial is testing

Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

Who this might be right for
Advanced Urothelial CarcinomaLocally Advanced Urothelial CarcinomaMetastatic Urothelial Carcinoma+4 more
National Cancer Institute (NCI) 171
Testing effectiveness (Phase 2)Ended earlyNCT04322643
What this trial is testing

Intermittent Checkpoint Inhibitor Therapy In Patients With Advanced Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Case Comprehensive Cancer Center 4
Large-scale testing (Phase 3)Study completedNCT02818725
What this trial is testing

I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations

Who this might be right for
Infiltrating Urothelial CarcinomaKRAS Gene Mutation
UNICANCER 133
Early research (Phase 1)Active Not RecruitingNCT02496208
What this trial is testing

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

Who this might be right for
Bladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more
National Cancer Institute (NCI) 152
Not applicableLooking for participantsNCT07548476
What this trial is testing

Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy

Who this might be right for
Metastatic Bladder CancerPeripheral NeuropathyAdvanced Urothelial Cancer+3 more
Dana-Farber Cancer Institute 20
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Early research (Phase 1)UnknownNCT05311618
What this trial is testing

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 71
Testing effectiveness (Phase 2)Looking for participantsNCT04198766
What this trial is testing

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+5 more
Inhibrx Biosciences, Inc 340
Large-scale testing (Phase 3)Active Not RecruitingNCT03682068
What this trial is testing

Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer

Who this might be right for
Unresectable Locally Advanced Urothelial CancerMetastatic Urothelial Cancer
AstraZeneca 1,246
Next Page